Probiotics and prevention of Clostridium difficile infection-Reference-Cited by-同舟云学术

Probiotics and prevention of Clostridium difficile infection

Published:2017-06 Issue: Volume:45 Page:114-119
ISSN:1075-9964
Container-title:Anaerobe
language:en
Short-container-title:Anaerobe

Author:

Goldstein E.J.C.,Johnson S.J.,Maziade P.-J.,Evans C.T.,Sniffen J.C.,Millette M.,McFarland L.V.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference50 articles.

1. Center for Disease Control and Prevention. Antibiotic resistance threats in the United States 2013. Http://cdc.gov/drugresistance/threat.report-2013/. Accessed 10-12-16.

2. Current trends in the epidemiology and outcomes of Clostridium difficile infection;Evans;Clin. Infect. Dis.,2015

3. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin;Figueroa;Clin. Infect. Dis.,2012

4. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes;Johnson;J. Infect.,2009

5. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada;Pepin;Clin. Infect. Dis.,2005

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lactobacillus acidophilus LA-5 Ameliorates Inflammation and Alveolar Bone Loss Promoted by A. actinomycetemcomitans and S. gordonii in Mice and Impacts Oral and Gut Microbiomes;Microorganisms;2024-04-22

2. Acidification-dependent suppression ofC. difficileby enterococci in vitro;2023-05-19

3. Plant-Derived Xanthones against Clostridial Enteric Infections;Antibiotics;2023-01-21

4. Contribution of Lactobacilli on Intestinal Mucosal Barrier and Diseases: Perspectives and Challenges of Lactobacillus casei;Life;2022-11-16

5. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort;Microbiology Spectrum;2022-08-31